Experts (National Institute of Oncology): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forpatients</span> <span style="display:none"> | <span style="display:none">forproviders</span> <span style="display:none">forpatients</span> | ||
<span style="display:none">hungarycountry</span> | |||
Go back to [[National Institute of Oncology]] page | Go back to [[National Institute of Oncology]] page | ||
| Line 43: | Line 44: | ||
'''[https://onkol.hu/urogenitalis-tumorok-es-klinikai-farmakologiai-osztaly-kemotarapia-c/ Urogenital Tumours and Department of Clinical Pharmacology (Chemotherapy C)]''' | '''[https://onkol.hu/urogenitalis-tumorok-es-klinikai-farmakologiai-osztaly-kemotarapia-c/ Urogenital Tumours and Department of Clinical Pharmacology (Chemotherapy C)]''' | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Latest revision as of 12:31, 6 December 2025
Go back to National Institute of Oncology page
Departments[edit | edit source]
Anesthesiology and Intensive Care
Breast - Soft Tissue Tumour Surgery
Oncology Imaging and Invasive Diagnostic Center
Drug Therapy Center[edit | edit source]
Dermato-Oncology Departmente (Chemotherapy D)
Hematology and Lymphoma (Chemotherapy A)
Thoracic and Abdominal Tumours and Department of Clinical Pharmacology (Chemotherapy B)
Urogenital Tumours and Department of Clinical Pharmacology (Chemotherapy C)
